CN1299113C - Inspection for quality control of Longxuejie - Google Patents
Inspection for quality control of Longxuejie Download PDFInfo
- Publication number
- CN1299113C CN1299113C CNB2005100108515A CN200510010851A CN1299113C CN 1299113 C CN1299113 C CN 1299113C CN B2005100108515 A CNB2005100108515 A CN B2005100108515A CN 200510010851 A CN200510010851 A CN 200510010851A CN 1299113 C CN1299113 C CN 1299113C
- Authority
- CN
- China
- Prior art keywords
- dragon
- blood
- ascarin
- solution
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明涉及一种中药材原料药的检测方法,尤其是可以用以进行质量控制的成分的检测方法。发明所述的龙血竭质量控制检测方法是用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B含量的方法。本发明所述的龙血竭质量控制检测方法由以下步骤组成:一、色谱条件与系统适用性试验;二、对照品溶液的制备;三、供试品溶液的制备;四、测定。为了全面、准确地控制龙血竭的质量,本发明制定了用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B的含量。经分析方法验证,其精密度、重现性、回收率和稳定性符合中国药典2000年一部附录《中药质量标准分析方法验证指导原则》的要求。The invention relates to a method for detecting raw materials of Chinese medicinal materials, in particular to a method for detecting components that can be used for quality control. The quality control detection method of dragon blood jerky described in the invention is a method for simultaneously determining the contents of dragon blood jelly A and dragon blood jelly B by high performance liquid chromatography. The quality control detection method of Dracaena dracaena of the present invention consists of the following steps: 1. Chromatographic conditions and system applicability test; 2. Preparation of reference solution; 3. Preparation of test solution; 4. Determination. In order to comprehensively and accurately control the quality of dragon's blood, the present invention formulates a high-performance liquid chromatography method for simultaneously determining the contents of dragon's blood A and dragon's blood in dragon's blood. After the verification of the analytical method, its precision, reproducibility, recovery rate and stability meet the requirements of the Chinese Pharmacopoeia 2000, an appendix "Guiding Principles for the Validation of Analytical Methods of Quality Standards for Traditional Chinese Medicine".
Description
技术领域technical field
本发明涉及一种中药材原料药的检测方法,尤其是可以用以进行质量控制的成分的检测方法。The invention relates to a method for detecting raw materials of Chinese medicinal materials, in particular to a method for detecting components that can be used for quality control.
背景技术Background technique
龙血竭为龙舌兰科植物剑叶龙血树Dracaeua cochinchinensis(Lour.)S.H.Chen含脂木质部经提取加工成的树脂,为常用中药,有活血散瘀,定痛止血,敛疮生肌功效,主要用于跌打损伤,瘀血作痛,妇女气血凝滞,外伤出血,褥疮久不收口。已收载于国家药品标准WS3-082(Z-016)-99(Z)。目前所执行的标准质量控制只测定龙血素B(C18H20O5)的含量,经研究发现,龙血竭中主要成分为黄酮类,仅仅只控制药材中一种黄酮的量难以准确地反映产品质量。Dracaena cochinchinensis (Lour.) Dracaeua cochinchinensis (Lour.) SHChen, a plant of the family Agaveaceae, is a resin extracted and processed from the lipid-containing xylem. It is a commonly used traditional Chinese medicine. It is mainly used for bruises, blood stasis and pain, stagnation of Qi and blood in women, traumatic bleeding, and bedsores that persist for a long time. It has been included in the national drug standard WS3-082(Z-016)-99(Z). The currently implemented standard quality control only measures the content of dracaena B (C 18 H 20 O 5 ). It is found through research that the main components of dracaena japonicus are flavonoids, and it is difficult to accurately control the amount of only one type of flavonoid in the medicinal material. reflect product quality.
发明内容Contents of the invention
本发明的目的是提供一种全面、准确的控制龙血竭质量的龙血竭质量控制检测方法。The purpose of the present invention is to provide a comprehensive and accurate quality control detection method for dragon's blood to control the quality of dragon's blood.
本发明所述的龙血竭质量控制检测方法是用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B含量的方法。The quality control detection method of dragon's blood in the invention is a method for simultaneously measuring the contents of dragon's blood A and dragon's blood in dragon's blood by high-performance liquid chromatography.
为了全面、准确地控制龙血竭的质量,申请人对龙血竭中黄酮类成分进行了研究,提出增加其中含量高、易定量的龙血素A(C17H18O4)的含量测定,结果表明,云南产龙血竭中龙血素A含量较广西产的高5至6倍,且不同产地龙血竭中龙血素A含量差异较大,据文献报道龙血素A(C17H18O4)、龙血素B(C18H20O5)属黄酮类查耳酮类化合物,是龙血竭的主要有效成分。为确保产品质量可控和安全有效,申请人研究制定了用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B的含量。经分析方法验证,其精密度、重现性、回收率和稳定性符合中国药典2000年一部附录《中药质量标准分析方法验证指导原则》的要求。In order to comprehensively and accurately control the quality of dragon's blood, the applicant has conducted research on flavonoids in dragon's blood, and proposed to increase the content of dragon's blood A (C 17 H 18 O 4 ), which is high in content and easy to quantify. , the results showed that the content of dracaine A in Dracaena dracaena produced in Yunnan was 5 to 6 times higher than that produced in Guangxi, and the content of dracaena in Dracaena dracaena from different origins was quite different. 17 H 18 O 4 ) and dragon's blood B (C 18 H 20 O 5 ) belong to the flavonoid chalcone compounds, and are the main active ingredients of dragon's blood. In order to ensure that the product quality is controllable, safe and effective, the applicant has researched and developed a high-performance liquid chromatography method for the simultaneous determination of the contents of dracaine A and dracaine B in dragon's blood. After the verification of the analytical method, its precision, reproducibility, recovery rate and stability meet the requirements of the Chinese Pharmacopoeia 2000, an appendix "Guiding Principles for the Validation of Analytical Methods of Quality Standards for Traditional Chinese Medicine".
本发明所述的龙血竭质量控制检测方法由以下步骤组成:Dragon's blood quality control detection method of the present invention is made up of the following steps:
一、色谱条件与系统适用性试验1. Chromatographic conditions and system suitability test
用十八烷基硅烷键合硅胶为填充剂;冰醋酸溶液1→100-乙腈63±1∶37±1为流动相,检测波长为275±2nm,柱温:30±1℃,理论板数按龙血素A及B峰计算均应不低于5000,龙血素A峰与B峰分离度应大于2.0;Octadecylsilane bonded silica gel is used as filler; glacial
二、对照品溶液的制备Two, the preparation of reference substance solution
称取经干燥剂减压干燥24小时的龙血素A、龙血素B对照品适量,加甲醇溶解并制成每1ml含龙血素A 0.18mg、含龙血素B 0.04mg的混合溶液,即得;Weigh an appropriate amount of ascarin A and ascarin B reference substances dried under reduced pressure by a desiccant for 24 hours, add methanol to dissolve and make a mixed solution containing 0.18 mg of ascarin A and 0.04 mg of ascarin B per 1 ml, instant;
三、供试品溶液的制备Three, the preparation of test solution
取本品粉末约0.25g,精密称定至25ml量瓶中,加入甲醇约20ml,超声处理10分钟使龙血竭溶解,放冷至室温,用甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,弃去初滤液,即得;Take about 0.25g of the powder of this product, accurately weigh it into a 25ml measuring bottle, add about 20ml of methanol, sonicate for 10 minutes to dissolve the dragon's blood, let it cool to room temperature, dilute to the mark with methanol, shake well, 0.45μm micropore Filtrate through a filter membrane, discard the initial filtrate, and obtain;
四、测定4. Determination
精密吸取对照品溶液10μl与供试品溶液5μl,注入液相色谱仪,测定,即得。Precisely draw 10 μl of the reference substance solution and 5 μl of the test solution, inject it into the liquid chromatograph, measure it, and obtain it.
本发明的方法学考察:Methodological investigation of the present invention:
线性关系考察:Linear relationship investigation:
分别精密吸取对照品溶液1、2、5、10、15、20ul,按上述色谱条件测定峰面积,结果见表1,采用Agilent色谱工作站Chem Station计算标准曲线,见图1、图2。以峰面积积分值对样量进行回归,龙血素A在0.1840μg---3.680μg、龙血素B在0.0419μg---0.8380μg范围内显现良好的线性关系。龙血素A回归方程为:Y=3411.92X+34.40,r=0.99989;龙血素B回归方程为:Y=2694.85X+14.79,r=0.99960;其中Y为峰面积,X为进样量,r为相关系数。Accurately draw 1, 2, 5, 10, 15, and 20 ul of the reference solution respectively, and measure the peak area according to the above-mentioned chromatographic conditions. The sample volume was regressed by the peak area integral value, and a good linear relationship was shown in the range of 0.1840 μg---3.680 μg for ascarin A and 0.0419 μg---0.8380 μg for ascarin B. The regression equation of dragon blood A is: Y=3411.92X+34.40, r=0.99989; the regression equation of dragon blood B is: Y=2694.85X+14.79, r=0.99960; where Y is the peak area, X is the injection volume, r is the correlation coefficient.
表1线性关系考察结果
精密度试验:Precision test:
取同一龙血素A及龙血素B对照品溶液,按上述色谱条件,连续测定6次(进样10μl),测得峰面积积分值见表2。Take the same reference substance solution of dragon blood A and dragon blood B, according to the above-mentioned chromatographic conditions, measure continuously 6 times (injection 10 μ l), the measured peak area integral value is shown in Table 2.
表2精密度试验结果
稳定性试验:Stability test:
取同一供试品溶液,按上述色谱条件,进样10μl,在不同时间测定,结果见表3。Take the same test solution, according to the above chromatographic conditions, inject 10 μl of sample, and measure at different times, the results are shown in Table 3.
表3稳定性试验结果
结果表明,样品在166hr(约7天)内比较稳定。The results showed that the sample was relatively stable within 166hr (about 7 days).
重现性试验:Reproducibility test:
取龙血竭粉末(过三号筛,小试样)约0.25g,共称取6份,按含量测定方法试验,结果见表4。Take about 0.25 g of dragon's blood powder (passed through No. 3 sieve, small sample), weigh 6 parts in total, and test according to the content determination method. The results are shown in Table 4.
表4重现性试验结果
结果表明,重现性良好。The results showed good reproducibility.
加样回收率试验:Sample recovery test:
取已测定含量龙血竭粉末(中试样品,010101;含龙血素A为2.80%、龙血素B为0.59%)约0.12g,共称取6份,精密称定,置25ml量瓶中,精密加入龙血素A及B对照品溶液(每1ml中含龙血素A 0.1840mg/ml、龙血素B 0.0419mg/ml)10、15、20ml,补加甲醇至约20ml,超声处理10min,放至室温,加入甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,取续滤液,测定含量并计算回收率,结果见表5、表6。Take about 0.12g of dragon’s blood jerky powder (pilot test sample, 010101; containing 2.80% asdracaine A and 0.59% asdracaine B) whose content has been determined, weigh 6 parts in total, weigh them accurately, and put them in 25ml volume In the bottle, add 10, 15, 20ml of dragon blood A and B reference solution (each 1ml contains dragon blood A 0.1840mg/ml, dragon blood B 0.0419mg/ml), add methanol to about 20ml, Sonicate for 10 minutes, let it cool to room temperature, add methanol to dilute to the mark, shake well, filter through a 0.45 μm microporous membrane, take the subsequent filtrate, measure the content and calculate the recovery rate, the results are shown in Table 5 and Table 6.
表5龙血素A加样回收率试验结果
表6龙血素B加样回收率试验结果
结果表明,本品加样回收率符合规定。The results show that the sample recovery rate of this product meets the requirements.
附图说明Description of drawings
图1为龙血素A标准曲线图。Figure 1 is a standard curve diagram of dragon blood A.
图2为龙血素B标准曲线图。Figure 2 is a standard curve diagram of dragon blood B.
具体实施方式Detailed ways
实施例:Example:
色谱条件与系统适用性试验 用十八烷基硅烷键合硅胶为填充剂;冰醋酸溶液(1→100)-乙腈(63∶37)为流动相,检测波长为275nm。柱温:30℃。理论板数按龙血素A及B峰计算均应不低于5000,龙血素A峰与B峰分离度应大于2.0。Chromatographic conditions and system suitability test Octadecylsilane bonded silica gel was used as filler; glacial acetic acid solution (1→100)-acetonitrile (63:37) was used as mobile phase, and the detection wavelength was 275nm. Column temperature: 30°C. The number of theoretical plates should not be less than 5,000 based on the calculation of the peaks A and B of dragon blood, and the separation degree between peak A and peak B of dragon blood should be greater than 2.0.
对照品溶液的制备 精密称取经五氧化二磷减压干燥24小时的龙血素A、龙血素B对照品适量,加甲醇溶解并制成每1ml含龙血素A 0.18mg、含龙血素B0.04mg的混合溶液,即得。Preparation of Reference Substance Solution Accurately weigh the appropriate amount of reference substances of dragon blood A and dragon blood B which have been dried under reduced pressure by phosphorus pentoxide for 24 hours, add methanol to dissolve and make each 1ml containing dragon blood A 0.18mg, containing dragon blood A mixed solution of 0.04 mg of element B is obtained.
供试品溶液的制备 取本品粉末(过三号筛)约0.25g,精密称定至25ml量瓶中,加入甲醇约20ml,超声处理10分钟使龙血竭溶解,放冷至室温,用甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,弃去初滤液,即得。Preparation of the test solution Take about 0.25g of the powder of this product (passed through a No. 3 sieve), accurately weigh it into a 25ml measuring bottle, add about 20ml of methanol, and sonicate for 10 minutes to dissolve the dragon’s blood, let it cool to room temperature, and use Dilute with methanol to the mark, shake well, filter through a 0.45 μm microporous membrane, discard the initial filtrate, and obtain the product.
测定法 精密吸取对照品溶液10μl与供试品溶液5μl,注入液相色谱仪,测定,即得。Determination method Precisely draw 10 μl of the reference substance solution and 5 μl of the test solution, inject it into the liquid chromatograph, measure it, and obtain it.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100108515A CN1299113C (en) | 2005-06-13 | 2005-06-13 | Inspection for quality control of Longxuejie |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100108515A CN1299113C (en) | 2005-06-13 | 2005-06-13 | Inspection for quality control of Longxuejie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1712953A CN1712953A (en) | 2005-12-28 |
| CN1299113C true CN1299113C (en) | 2007-02-07 |
Family
ID=35718656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100108515A Expired - Lifetime CN1299113C (en) | 2005-06-13 | 2005-06-13 | Inspection for quality control of Longxuejie |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1299113C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101780191B (en) * | 2009-01-20 | 2013-09-04 | 江苏康缘药业股份有限公司 | Method for controlling quality of Resina Draconis-drug extract |
| CN101780189B (en) * | 2009-01-20 | 2013-03-20 | 江苏康缘药业股份有限公司 | Method for detecting Resina Draconis drug |
| CN101780190B (en) * | 2009-01-20 | 2013-05-01 | 江苏康缘药业股份有限公司 | Detection method for pharmaceutic preparation containing sanguis draconis extract |
| CN102081074B (en) * | 2009-11-30 | 2013-09-11 | 昆明制药集团股份有限公司 | Quality detection method for 2'-hydroxy-4,4',5',6'-tetramethyl-tetramethoxide chalcone |
| CN102359996A (en) * | 2011-05-13 | 2012-02-22 | 云南大唐汉方制药有限公司 | Quality detection method for dranaena cochinchinensis |
| CN102885801B (en) * | 2012-09-28 | 2014-12-17 | 中国人民解放军第四军医大学 | Application of Chinese medicinal monomer compound extracted from dragon's blood |
| CN103760219B (en) * | 2014-01-16 | 2016-04-06 | 江苏康缘药业股份有限公司 | A kind of method based on multiple liposoluble ingredient in DART/Q-TOF method Analysis and Identification Resina Draconis |
| CN106950304B (en) * | 2017-03-23 | 2019-10-29 | 北京中医药大学 | The quality determining method of Resina Draconis phenols extract and its preparation |
| CN112684093B (en) * | 2020-12-08 | 2022-11-25 | 广西中医药大学 | A quality detection method for eleven prescription medicinal wine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030157197A1 (en) * | 1998-10-27 | 2003-08-21 | Okunji Christopher O. | Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| CN1481788A (en) * | 2002-09-12 | 2004-03-17 | 江苏康缘药业股份有限公司 | A preparation method and quality control method of dragon's blood jerky total flavonoids preparation |
-
2005
- 2005-06-13 CN CNB2005100108515A patent/CN1299113C/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030157197A1 (en) * | 1998-10-27 | 2003-08-21 | Okunji Christopher O. | Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| CN1481788A (en) * | 2002-09-12 | 2004-03-17 | 江苏康缘药业股份有限公司 | A preparation method and quality control method of dragon's blood jerky total flavonoids preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1712953A (en) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108760903B (en) | Fingerprint spectrum determination method for Shuanghuanglian oral preparation | |
| CN1299113C (en) | Inspection for quality control of Longxuejie | |
| CN106770828B (en) | A kind of method for simultaneous determination of multicomponent content in Ginkgo biloba extract and its preparation | |
| CN101647829B (en) | A kind of high performance liquid chromatography detection method of ginkgolide injection | |
| CN115980202B (en) | HPLC Detection Method for Related Substances in Bromhexine Hydrochloride API | |
| CN107860832A (en) | The method for building up of compound rubarb Qi Yi Tang finger-print | |
| CN107064322B (en) | HPLC Wavelength Switching Method for Simultaneous Determination of Gallic Acid and Burnet Saponin I in Burnet or Burnet Preparations | |
| CN103822975B (en) | A kind of detection method of formulation of ' Sheng Mai ' of Radix Codonopsis side | |
| CN104807896A (en) | Identification and content determination method of traditional Chinese medicine gelata | |
| CN108896681B (en) | Nerve-soothing brain-tonifying liquid multi-index quantitative fingerprint establishment method and application thereof | |
| CN109655558B (en) | A kind of detection method of effective parts group of black bone vine | |
| CN107389821A (en) | A kind of method of active ingredient in measure ageratum oral liquid | |
| CN102735772A (en) | Quality controlling method of ganoderma aqueous extract | |
| CN111796047B (en) | Method for establishing fingerprint characteristic spectrum of Reyanning preparation and application thereof | |
| CN1790013A (en) | Method for simultaneous determination of protocatechuic acid content and 5-hydroxymethyl furfural content in pulse-activating injection | |
| CN111089930B (en) | A method for constructing UPLC characteristic map of Xinyi formula granules and its component content determination | |
| CN111323508B (en) | Method for determining content of 2, 4-dihydroxy-6-methoxyacetophenone in blumea balsamifera oil | |
| CN116381088A (en) | A method and application of multi-component content determination based on HPLC dual-wavelength gradient elution | |
| CN104267114A (en) | Detection method of nymphaea candida presl | |
| CN1515904A (en) | A kind of gastrodin content assay method | |
| CN116559302A (en) | Application of wall grass alkali in kadsura pepper stem sample quality detection and corresponding quality detection method | |
| CN113917039A (en) | Method for measuring content of effective components in pepper and products thereof | |
| CN115993415B (en) | A new method for detecting polymer content in cefcapone hydrochloride | |
| CN102379934A (en) | High efficiency liquid chromatography detection method for content of raddeanin A in rhizoma anemones raddeanae | |
| CN113533598B (en) | High performance liquid chromatography analysis method for content of scutellaria baicalensis in infantile lung heat cough and asthma granules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SHANGHAI DIHON MEDICAL CO.,LTD. Assignor: KUNMING DIHON PHARMACEUTICAL Ltd. Contract fulfillment period: 2009.10.25 to 2017.10.25 Contract record no.: 2009530000048 Denomination of invention: Inspection for quality control of Longxuejie Granted publication date: 20070207 License type: Common License Record date: 20091202 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: COMMON LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.10.25 TO 2017.10.25; CHANGE OF CONTRACT Name of requester: SHANGHAI DIHON PHARMACEUTICAL CO., LTD. Effective date: 20091202 |
|
| C56 | Change in the name or address of the patentee |
Owner name: DIHON PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: KUNING DIANHONG PHARMACEUTICAL CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: 650106 Kunming science and Technology Development Zone, Yunnan Province Road No. 45 Patentee after: DIHON PHARMACEUTICAL GROUP Co.,Ltd. Address before: 650106 No. 45, medical Road, Kunming hi tech Industrial Development Zone, Yunnan, Kunming Patentee before: KUNMING DIHON PHARMACEUTICAL Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20191225 Address after: 650503 1298 Bio Valley Street, majinpu, Kunming, Yunnan Patentee after: Yunnan Shengke Pharmaceutical Co.,Ltd. Address before: 650106 No. 45, medical Road, hi tech Development Zone, Yunnan, Kunming Patentee before: DIHON PHARMACEUTICAL GROUP Co.,Ltd. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20070207 |